Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Presence of histopathological premalignant lesions and infection caused by high-risk genotypes of human papillomavirus in patients with suspicious cytological and colposcopy results: A prospective study.

Golubović M, Lopičić M, Terzić N, Đurović M, Mugoša B, Mijović G.

Vojnosanit Pregl. 2017 Jan;74(1):24-30. doi: 10.2298/VSP150205143G.

PMID:
29350503
2.

Co-expression of p53 and Bcl-2 proteins in human papillomavirus-induced premalignant lesions of the uterine cervix: correlation with progression to malignancy.

Singh M, Srivastava S, Singh U, Mathur N, Shukla Y.

Tumour Biol. 2009;30(5-6):276-85. doi: 10.1159/000259911. Epub 2009 Nov 20.

PMID:
19940548
3.

DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions.

Oikonomou P, Messinis I, Tsezou A.

Exp Biol Med (Maywood). 2007 Jul;232(7):881-6.

PMID:
17609503
4.

Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.

Santos M, Montagut C, Mellado B, García A, Ramón y Cajal S, Cardesa A, Puig-Tintoré LM, Ordi J.

Int J Gynecol Pathol. 2004 Jul;23(3):206-14.

PMID:
15213596
5.

Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12.

Hernandez BY, McDuffie K, Wilkens LR, Kamemoto L, Goodman MT.

Cancer Causes Control. 2003 Nov;14(9):859-70.

PMID:
14682443
6.

[Contribution of high risk human papillomavirus testing to the management of premalignant and malignant lesions of the uterine cervix].

Ordi J, Puig-Tintoré LM, Torné A, Sanz S, Esteve R, Romagosa C, Cardesa A.

Med Clin (Barc). 2003 Oct 11;121(12):441-5. Spanish.

PMID:
14572367
7.

Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer.

Baay MF, Tjalma WA, Weyler J, Goovaerts G, Buytaert P, Van Marck EA, Lardon F, Vermorken JB.

Eur J Gynaecol Oncol. 2001;22(3):204-8.

PMID:
11501772
8.
9.
10.

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.

Cromme FV, Meijer CJ, Snijders PJ, Uyterlinde A, Kenemans P, Helmerhorst T, Stern PL, van den Brule AJ, Walboomers JM.

Br J Cancer. 1993 Jun;67(6):1372-80.

Supplemental Content

Loading ...
Support Center